Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease
Autor: | Suresh Senan, Idris Bahce, Chris Dickhoff, Esther J. Nossent, Femke O.B. Spoelstra, Suzan F M Nijman, Merle I Ronden-Kianoush, Tobias Finazzi |
---|---|
Přispěvatelé: | Academic Medical Center, Pulmonary medicine, APH - Quality of Care, APH - Personalized Medicine, Radiation Oncology, CCA - Cancer Treatment and quality of life, Cardio-thoracic surgery |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Male
medicine.medical_specialty Lung Neoplasms medicine.medical_treatment Kaplan-Meier Estimate SABR volatility model Magnetic Resonance Imaging Interventional Radiosurgery Severity of Illness Index 030218 nuclear medicine & medical imaging 03 medical and health sciences Pneumonectomy 0302 clinical medicine Carcinoma Non-Small-Cell Lung Ablative case medicine Carcinoma Humans Radiology Nuclear Medicine and imaging Stage (cooking) Lung cancer Radiation Injuries Lung Aged Neoplasm Staging Aged 80 and over business.industry Radiotherapy Planning Computer-Assisted Interstitial lung disease Radiotherapy Dosage Hematology General Medicine Cone-Beam Computed Tomography medicine.disease respiratory tract diseases Radiation therapy Treatment Outcome Oncology 030220 oncology & carcinogenesis Female Radiotherapy Adjuvant Radiology business Lung Diseases Interstitial Follow-Up Studies |
Zdroj: | Acta oncologica (Stockholm, Sweden), 59(5), 569-573. Informa Healthcare Finazzi, T, Ronden-Kianoush, M I, Spoelstra, F O B, Nossent, E J, Nijman, S F M, Bahce, I, Dickhoff, C & Senan, S 2020, ' Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease ', Acta Oncologica, vol. 59, no. 5, pp. 569-573 . https://doi.org/10.1080/0284186X.2020.1730002 Acta Oncologica, 59(5), 569-573. Informa Healthcare |
ISSN: | 0284-186X |
Popis: | Stereotactic ablative radiotherapy (SABR) is the preferred treatment in medically inoperable patients with early-stage non-small cell lung cancer (NSCLC) [1]. However, there is growing awareness of... |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |